COMMONWEALTH EQUITY SERVICES, LLC

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 312272 WALTHAM, MA

Position in RXRX

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$985,442

+$636,390 QoQ

Shares Held

320,991

+276.1% QoQ

Ownership

0.061%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Healthcare · as of Mar 31, 2026

COMMONWEALTH EQUITY SERVICES, LLC holds $113,564,491 across 120 Biotechnology names. RXRX ranks #23 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	54,972	$24,547,196
2	REGN	Regeneron Pharmaceuticals, Inc.	16,385	$12,659,706
3	EXEL	Exelixis, Inc.	173,762	$7,452,652
4	TGTX	Tg Therapeutics, Inc.	180,285	$5,989,067
5	TARS	Tarsus Pharmaceuticals, Inc.	80,892	$5,674,573
6	CRSP	CRISPR Therapeutics AG	78,488	$3,733,674
7	ALNY	Alnylam Pharmaceuticals, Inc.	10,577	$3,499,611
8	ARWR	Arrowhead Pharmaceuticals, Inc.	55,076	$3,453,265

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$985,442	320,991	+276.1%	Shares	Sole	2026-04-27
2025-12-31	$349,052	85,343	+85.4%	Shares	Sole	2026-02-12
2025-09-30	$224,675	46,040	-22.8%	Shares	Sole	2025-10-22
2025-06-30	$301,682	59,621	-10.1%	Shares	Sole	2025-08-06
2025-03-31	$350,954	66,343	+22.1%	Shares	Sole	2025-05-09
2024-12-31	$367,196	54,319	-7.8%	Shares	Sole	2025-02-10
2024-09-30	$388,157	58,901	+33.1%	Shares	Sole	2024-10-18
2024-06-30	$331,807	44,241	+25.7%	Shares	Sole	2024-07-31
2024-03-31	$350,774	35,183	+59.9%	Shares	Sole	2024-04-29
2023-12-31	$216,920	22,000	+3.8%	Shares	Sole	2024-02-06
2023-09-30	$162,065	21,185	+35.5%	Shares	Sole	2023-10-23
2023-06-30	$116,793	15,635	—	Shares	Sole	2023-08-10
No filing history on record for this holder in this stock.